Some new approaches to the management of hepatocellular carcinoma

Seminars in Oncology

Volumn 39, Issue 4, 2012, Pages 369-373

  Carr, Brian I ^a,b  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BEVACIZUMAB; BRIVANIB; CD133 ANTIGEN; DECARBOXYPROTHROMBIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL CELL ADHESION MOLECULE; ERLOTINIB; EVEROLIMUS; GLYPICAN 3; HERMES ANTIGEN; HISTONE DEACETYLASE; LINIFANIB; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NESTIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; RAMUCIRUMAB; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C; SORAFENIB; TIVANTINIB; UBIQUITIN; VASCULOTROPIN; VEMURAFENIB; WNT PROTEIN; YTTRIUM 90;

APOPTOSIS; AUTOPHAGY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL GROWTH; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; GENE MUTATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOGENOMICS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTION; PRIORITY JOURNAL; PROTON THERAPY; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR VASCULARIZATION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; PROTEIN KINASE INHIBITORS;

EID: 84864469098     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.05.007     Document Type: Conference Paper

References (22)

1. R. Yamada, M. Sato, M. Kawabata Hepatic artery embolization in 120 patients with unresectable hepatoma Radiology 148 1983 397 401
2. S. Iwatsuki, T.E. Starzl, D.G. Sheahan Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 221 228
3. B. Ringe, R. Pichlmayr, C. Wittekind, G. Tusch Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients World J Surg 15 1991 270 285
4. J.M. Llovet, S. Ricci, V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
5. C. Frenette, R. Gish Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications World J Gastroenterol 18 2012 498 506
6. A.O. Kaseb, E. Garrett-Mayer, J.S. Morris Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial Oncology 82 2012 67 74
7. B.I. Carr, V. Kondragunta, S.C. Buch, R.A. Branch Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study Cancer 116 2010 1305 1314
8. C.M. Lo, H. Ngan, W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
9. J.M. Llovet, M.I. Real, X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
10. G. Poggi, B. Montagna, F. Melchiorre Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma Anticancer Res 31 2011 3927 3933
11. S.A. Rosenzweig Acquired resistance to drugs targeting receptor tyrosine kinases Biochem Pharmacol 83 2012 1041 1048
12. T. Muranen, L.M. Selfors, D.T. Worster Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells Cancer Cell 21 2012 227 239
13. I.H. Wong, W.Y. Lau, T. Leung Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis Clin Cancer Res 5 1999 4021 4027
14. S. Kar, B.I. Carr Detection of liver cells in peripheral blood of patients with advanced stage hepatocellular carcinoma Hepatology 21 2005 403 407
15. E. Boucher, S. Corninais, Y. Rolland Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma Hepatology 38 2003 1237 1241
16. Y. Hoshida, A. Villanueva, M. Kobayashi Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
17. M. Okamoto, T. Utsunomiya, S. Wakiyama Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients Ann Surg Oncol 13 2006 947 954
18. B.I. Carr, P. Pancoska, R.A. Branch HCC in older patients Dig Dis Sci 2010 3584 3590
19. B. Minguez, A. Lachenmayer Diagnostic and prognostic molecular markers in hepatocellular carcinoma Dis Markers 31 2011 181 190
20. Z. Liu, Y. Ma, J. Yang, H. Qin Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies OMICS 15 2011 61 71
21. J.M. Llovet, C. Pena, C. Lathia Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma Clin Cancer Res. Feb 28 2012 Epub ahead of print
22. H.G. Woo, E.S. Park, S.S. Thorgeirsson, Y.J. Kim Exploring genomic profiles of hepatocellular carcinoma Mol Carcinog 50 2011 235 243